Growth Metrics

Gyre Therapeutics (GYRE) Assets (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.48%
Dec 31, 2025 4.23%
Sep 30, 2025 4.41%
Jun 30, 2025 17.61%
Mar 31, 2025 3.50%
Dec 31, 2024 0.13%
Sep 30, 2024 3.56%
Jun 30, 2024 -0.89%
Mar 31, 2024 4.69%
Dec 31, 2023 1,069.60%
Sep 30, 2023 -19.61%
Jun 30, 2023 -33.90%
Mar 31, 2023 -77.88%
Dec 31, 2022 173.23%
Sep 30, 2022 -62.79%
Jun 30, 2022 107.01%
Mar 31, 2022 -27.65%
Dec 31, 2021 -29.13%
Sep 30, 2021 -22.84%
Jun 30, 2021 -14.52%
Mar 31, 2021 25.55%
Dec 31, 2020 -15.17%
Sep 30, 2020 -9.61%
Jun 30, 2020 11.87%
Mar 31, 2020 12.19%
Dec 31, 2019 7.37%
Sep 30, 2019 -9.00%
Jun 30, 2019 -9.83%
Mar 31, 2019 -10.45%
Dec 31, 2018 -6.37%
Sep 30, 2018 -4.39%
Jun 30, 2018 -4.35%
Mar 31, 2018 269.21%
Dec 31, 2017 14.89%
Sep 30, 2017 -13.21%
Jun 30, 2017 36.37%
Mar 31, 2017 -23.71%
Dec 31, 2016 -26.21%
Sep 30, 2016 -9.79%
Jun 30, 2016 -7.03%
Mar 31, 2016 -11.48%
Dec 31, 2015 -6.70%
Sep 30, 2015 -26.35%
Jun 30, 2015 -5.56%
Mar 31, 2015 3,493.96%
Dec 31, 2014 -97.43%
Sep 30, 2014 -6.74%
Jun 30, 2014 -7.15%
Mar 31, 2014 -8.07%
Dec 31, 2013 -7.59%
Sep 30, 2013 -5.76%
Jun 30, 2013 -6.30%
Mar 31, 2013 -5.71%
Dec 31, 2012 -6.84%
Sep 30, 2012 -4.29%
Jun 30, 2012 -8.00%
Mar 31, 2012 -10.47%
Dec 31, 2011 -7.73%
Sep 30, 2011 -6.76%